These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9263663)

  • 1. Metabolic abnormalities in hypertension.
    Afonso LC; Edelson GW; Sowers JR
    Curr Opin Nephrol Hypertens; 1997 May; 6(3):219-23. PubMed ID: 9263663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia.
    Flack JM; Sowers JR
    Am J Med; 1991 Jul; 91(1A):11S-21S. PubMed ID: 1867224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women.
    Os I; Nordby G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S15-21. PubMed ID: 1283764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data].
    Valensi P
    Presse Med; 1992 Sep; 21(28):1307-11. PubMed ID: 1438099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension as a metabolic disorder--an overview.
    Smith U; Gudbjörnsdottir S; Landin K
    J Intern Med Suppl; 1991; 735():1-7. PubMed ID: 2043218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.
    Ferrari P; Weidmann P; Shaw S; Giachino D; Riesen W; Allemann Y; Heynen G
    Am J Med; 1991 Dec; 91(6):589-96. PubMed ID: 1750428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease.
    Reaven GM
    Am Heart J; 1991 Apr; 121(4 Pt 2):1283-8. PubMed ID: 2008857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertension as a part of metabolic cardiovascular syndrome].
    Os I; Hjermann I; Nordby G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic abnormalities in cardiac ischemia.
    Walsh MF; Dominguez LJ; Sowers JR
    Cardiol Clin; 1995 Nov; 13(4):529-38. PubMed ID: 8565016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension.
    Reaven GM
    Am J Med; 1991 Feb; 90(2A):7S-12S. PubMed ID: 1994722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes.
    Sheu WH; Jeng CY; Young MS; Le WJ; Chen YT
    Am J Med Sci; 2000 Feb; 319(2):84-8. PubMed ID: 10698091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic interrelationships, cardiovascular disease, and sex steroids.
    Fotherby K
    Contraception; 1998 Mar; 57(3):183-7. PubMed ID: 9617534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease.
    Landin K; Tengborn L; Smith U
    J Intern Med; 1990 Apr; 227(4):273-8. PubMed ID: 2182759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperinsulinemia and arterial hypertension].
    Kuzmanić D; Jelaković B
    Lijec Vjesn; 1996 Mar; 118 Suppl 1():57-61. PubMed ID: 8759412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web.
    DeFronzo RA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S1-16. PubMed ID: 1284137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to metabolic actions of insulin and its role in hypertension.
    Hall JE; Summers RL; Brands MW; Keen H; Alonso-Galicia M
    Am J Hypertens; 1994 Aug; 7(8):772-88. PubMed ID: 7986471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors?
    Lind L; Lithell H; Pollare T
    J Hypertens Suppl; 1993 Jun; 11(4):S11-6. PubMed ID: 8377030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women.
    Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Notkola IL; Takala JK
    J Hypertens; 1997 May; 15(5):475-81. PubMed ID: 9169999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.